• Publications
  • Influence
Immunosuppressive properties of human umbilical cord‐derived mesenchymal stem cells: role of B7‐H1 and IDO
Umbilical cord is a rich source of mesenchymal stromal or stem cells (MSCs) that can be used for developing allogeneic cell therapy to treat intractable diseases. In this report, we present evidenceExpand
  • 171
  • 13
The transdifferentiation potential of limbal fibroblast-like cells.
We report the identification and isolation of limbal fibroblast-like cells from adult corneo-limbal tissue possessing self-renewing capacity and multilineage differentiation potential. The cells formExpand
  • 53
  • 5
Tansplantation of autologous bone marrow derived mesenchymal stem cells trans-epicardially in patients undergoing coronary bypass surgery.
BACKGROUND Myocardial Infarction (MI) hampers cardiac performance by ventricular remodeling which is a major cause of heart failure or death. Conventional drug therapies like beta blockers,Expand
  • 15
  • 1
Umbilical cord matrix derived mesenchymal stem cells can change the cord blood transplant scenario.
BACKGROUND AND OBJECTIVES The field of Umbilical cord blood (UCB) hematopoietic stem cell transplantation has had an amazing run since 1988. UCB is being increasing used in related and unrelatedExpand
  • 6
  • 1
Characterization and in vitro differentiation potential of a new human embryonic stem cell line, ReliCell®hES1
Human embryonic stem cells (hESCs) are an exceptionally useful tool for studies of human development and represent a potential source for transplantation therapies. At present, only a limited numberExpand
  • 32
Characterization and in vitro differentiation potential of a new human embryonic stem cell line, ReliCellhES1.
Human embryonic stem cells (hESCs) are an exceptionally useful tool for studies of human development and represent a potential source for transplantation therapies. At present, only a limited numberExpand
  • 19
Immunologic properties of human dermal fibroblasts.
Human dermal fibroblasts are known not to express human leukocyte antigen (HLA)-DR message or protein in the absence of interferon (IFN)-γ. To use allogeneic dermal fibroblasts for cell therapy, as aExpand
  • 8
Radiolabeling of umbilical cord-derived mesenchymal stem cells for in vivo tracking.
Non-invasive methods for the assessment of distribution, homing, and retention of stem cells are desired for the successful demonstration of stem cell therapy. Cells labeled with (99m)Tc, (18)F, andExpand
  • 8